Tokyo - Delayed Quote JPY

Genky DrugStores Co., Ltd. (9267.T)

Compare
2,550.00
-139.00
(-5.17%)
At close: 3:30:00 PM GMT+9
Loading Chart for 9267.T
  • Previous Close 2,689.00
  • Open 2,489.00
  • Bid 2,550.00 x --
  • Ask 2,570.00 x --
  • Day's Range 2,455.00 - 2,613.00
  • 52 Week Range 2,455.00 - 3,865.00
  • Volume 72,500
  • Avg. Volume 52,247
  • Market Cap (intraday) 77.51B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 11.93
  • EPS (TTM) 213.78
  • Earnings Date Apr 23, 2025 - Apr 28, 2025
  • Forward Dividend & Yield 13.00 (0.48%)
  • Ex-Dividend Date Jun 19, 2025
  • 1y Target Est 4,400.00

Genky DrugStores Co., Ltd. operates a chain of drug stores. The company was founded in 1988 and is headquartered in Sakai, Japan.

www.genkydrugstores.co.jp

1,661

Full Time Employees

June 20

Fiscal Year Ends

Recent News: 9267.T

View More

Performance Overview: 9267.T

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

9267.T
18.40%
Nikkei 225 (^N225)
21.95%

1-Year Return

9267.T
19.40%
Nikkei 225 (^N225)
20.15%

3-Year Return

9267.T
32.18%
Nikkei 225 (^N225)
15.80%

5-Year Return

9267.T
157.91%
Nikkei 225 (^N225)
64.31%

Compare To: 9267.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9267.T

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    81.73B

  • Enterprise Value

    107.69B

  • Trailing P/E

    12.58

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.43

  • Price/Book (mrq)

    1.64

  • Enterprise Value/Revenue

    0.56

  • Enterprise Value/EBITDA

    7.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.39%

  • Return on Assets (ttm)

    5.05%

  • Return on Equity (ttm)

    13.93%

  • Revenue (ttm)

    191.65B

  • Net Income Avi to Common (ttm)

    6.5B

  • Diluted EPS (ttm)

    213.78

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.94B

  • Total Debt/Equity (mrq)

    66.08%

  • Levered Free Cash Flow (ttm)

    930.25M

Research Analysis: 9267.T

View More

Company Insights: 9267.T

Research Reports: 9267.T

View More

People Also Watch